177 related articles for article (PubMed ID: 17708609)
1. Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma.
Tangkijvanich P; Thong-Ngam D; Mahachai V; Theamboonlers A; Poovorawan Y
World J Gastroenterol; 2007 Aug; 13(32):4345-9. PubMed ID: 17708609
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis.
Ren Y; Poon RT; Tsui HT; Chen WH; Li Z; Lau C; Yu WC; Fan ST
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5996-6001. PubMed ID: 14676125
[TBL] [Abstract][Full Text] [Related]
3. Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma.
Iliaz R; Akyuz U; Tekin D; Serilmez M; Evirgen S; Cavus B; Soydinc H; Duranyildiz D; Karaca C; Demir K; Besisik F; Kaymakoglu S; Akyuz F
Arab J Gastroenterol; 2016 Dec; 17(4):164-167. PubMed ID: 27916547
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic role of serum interleukin-18 in gastric cancer patients.
Thong-Ngam D; Tangkijvanich P; Lerknimitr R; Mahachai V; Theamboonlers A; Poovorawan Y
World J Gastroenterol; 2006 Jul; 12(28):4473-7. PubMed ID: 16874857
[TBL] [Abstract][Full Text] [Related]
6. Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment.
Cho HJ; Kim SS; Ahn SJ; Park SY; Park JH; Kim JK; Wang HJ; Cheong JY; Cho SW
Cytokine; 2015 Jun; 73(2):245-52. PubMed ID: 25797190
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.
Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L
Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643
[TBL] [Abstract][Full Text] [Related]
8. High preoperative levels of serum glypican-3 containing N-terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomy.
Haruyama Y; Yorita K; Yamaguchi T; Kitajima S; Amano J; Ohtomo T; Ohno A; Kondo K; Kataoka H
Int J Cancer; 2015 Oct; 137(7):1643-51. PubMed ID: 25784484
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the role of interleukin-6 in diagnosis of hepatocellular carcinoma.
El-Folly RF; El-Kabarity RH; Arafa NA
Egypt J Immunol; 2010; 17(2):11-22. PubMed ID: 23082483
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
Kitaoka S; Shiota G; Kawasaki H
Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization.
Kim SS; Cho HJ; Won JH; Bae JI; Kang DR; Lee JD; Shin SJ; Lee KM; Yoo BM; Kim JK; Lee JH; Ahn SJ; Park JH; Cho SW; Cheong JY
Cytokine; 2015 Dec; 76(2):449-457. PubMed ID: 26163999
[TBL] [Abstract][Full Text] [Related]
12. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
13. Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences.
Nakagawa H; Maeda S; Yoshida H; Tateishi R; Masuzaki R; Ohki T; Hayakawa Y; Kinoshita H; Yamakado M; Kato N; Shiina S; Omata M
Int J Cancer; 2009 Nov; 125(10):2264-9. PubMed ID: 19585572
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma.
Jang JW; Oh BS; Kwon JH; You CR; Chung KW; Kay CS; Jung HS
Cytokine; 2012 Dec; 60(3):686-93. PubMed ID: 22906998
[TBL] [Abstract][Full Text] [Related]
15. Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory Response.
El-Emshaty HM; Nasif WA; Mohamed IE
Dis Markers; 2015; 2015():707254. PubMed ID: 26783377
[TBL] [Abstract][Full Text] [Related]
16. Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma.
Zhao YM; Wang L; Dai Z; Wang DD; Hei ZY; Zhang N; Fu XT; Wang XL; Zhang SC; Qin LX; Tang ZY; Zhou J; Fan J
Int J Cancer; 2011 Nov; 129(10):2463-72. PubMed ID: 21213214
[TBL] [Abstract][Full Text] [Related]
17. Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study.
Hayashi T; Yamashita T; Terashima T; Suda T; Okada H; Asahina Y; Hayashi T; Hara Y; Nio K; Sunagozaka H; Takatori H; Arai K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
BMC Cancer; 2017 Dec; 17(1):870. PubMed ID: 29258450
[TBL] [Abstract][Full Text] [Related]
18. Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma.
Spadaro A; Ajello A; Luigiano C; Morace C; Resta ML; Berlinghieri G; Campo S; Scisca C; Alibrandi A; D'Arrigo G; Alessi N; Ferrau O; Freni MA
World J Gastroenterol; 2006 Aug; 12(29):4716-20. PubMed ID: 16937445
[TBL] [Abstract][Full Text] [Related]
19. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis?
Hammad LN; Abdelraouf SM; Hassanein FS; Mohamed WA; Schaalan MF
J Immunotoxicol; 2013; 10(4):380-6. PubMed ID: 23350952
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma.
Tsuboi K; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Kato H; Kuwano H
Cancer Lett; 2004 Mar; 205(2):207-14. PubMed ID: 15036653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
